Tripos International Enters Into Agreement to Collaborate on a Molecular Invention Workflow for Drug Discovery With AstraZeneca PLC
ST. LOUIS, MO--(Marketwire - October 08, 2008) - Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution.